^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Epotin (epoetin alfa biosimilar)

    Associations

    News

    Trials
    Company:
    Claris
    Drug class:
    Erythropoiesis stimulating agent
    Related drugs:
    Associations

    News

    Trials
    over3years
    Assessment of iron metabolism disorders and adequate treatment of anemic syndrome in patients with breast cancer on the background of adjuvant chemotherapy. (PubMed, Klin Lab Diagn)
    AC correction was performed (ferinject, epotin-alpha, B12). The rational use of iron preparations, vitamins, and recombinant forms of EPO made it possible to restore Fe metabolism, stabilize the hemoglobin level, and also improve the condition of most breast cancer patients. The obtained data on IL-6, GP25, CRP indicate a certain relationship between them in the development of anemia with VDF in breast cancer patients and the need for further study of the characteristics of iron metabolism in cancer patients.
    Journal
    |
    HER-2 (Human epidermal growth factor receptor 2) • IL6 (Interleukin 6)
    |
    Epotin (epoetin alfa biosimilar)